Compound Transfer Program
Pfizer has an extensive pure substance library that encompasses all of our publicly known compounds. We review each request regarding use of our compounds for content, value, and consistency with Pfizer's direction for the requested compound. For approved requests Pfizer executes Compound Transfer Agreements (CTAs) that provide the compound free of charge to a third party to conduct the agreed upon study. Please note that while the compound and shipping are a gift, the recipient is responsible for any VAT taxes that may be applicable. We require a manuscript or report of the conclusions to bring closure to the study. Pfizer reserves the right to deny any request that we feel does not advance our compound(s) or add value to health.
To request a Pfizer compound please complete the submission form located on the INSPIIRE portal. The link is to the right or can be reached by pasting iirsubmission.pfizer.com into your browser. As part of the on-line submission application, an attachment with a full description of the specific research study proposed is required to be included. The on-line form, your attachment along with your CV will provide Pfizer with the information required to process your request.
Processing time from initial submission to the approved compound(s) shipment to your facility may take up to 12 weeks. You will receive an auto reply email confirming your submission has been completed and you may track the status of your submission on the INSPIIRE portal.
*Studies involving humans or requesting funding support should be submitted through the Investigator Initiated Research (IIR) program. For more information please click the following link which will take you to the Global Investigator Initiated Research section on the Pfizer website.